Header Logo

Etin-Osa Osa

Concepts (73)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiotherapy, Intensity-Modulated
1
2014
31
0.450
Why?
Patient Positioning
1
2014
44
0.440
Why?
Breast Neoplasms
4
2014
1118
0.420
Why?
Mastectomy, Segmental
2
2014
45
0.210
Why?
Radiotherapy Planning, Computer-Assisted
2
2014
55
0.200
Why?
Organs at Risk
1
2014
5
0.110
Why?
Prone Position
1
2014
27
0.110
Why?
Carcinoma, Lobular
1
2014
23
0.110
Why?
Neoplasms, Second Primary
1
2014
43
0.110
Why?
Carcinoma, Ductal, Breast
1
2014
45
0.110
Why?
Ovarian Follicle
1
2014
39
0.110
Why?
Radiation Injuries
1
2014
62
0.110
Why?
Chemotherapy, Adjuvant
1
2013
75
0.110
Why?
Neoadjuvant Therapy
1
2013
72
0.110
Why?
Anti-Mullerian Hormone
1
2014
62
0.110
Why?
Thymidine Phosphorylase
1
2012
4
0.100
Why?
Neoplasm Staging
1
2014
452
0.100
Why?
Deoxycytidine
1
2012
40
0.100
Why?
Fluorouracil
1
2012
55
0.100
Why?
Antimetabolites, Antineoplastic
1
2012
39
0.100
Why?
Breast
1
2014
173
0.100
Why?
X-Ray Intensifying Screens
1
2012
7
0.100
Why?
Feasibility Studies
1
2014
525
0.100
Why?
Radiotherapy, Conformal
1
2012
19
0.100
Why?
Radiometry
1
2012
35
0.100
Why?
Radiotherapy Dosage
1
2012
81
0.100
Why?
Neoplasm Recurrence, Local
1
2013
300
0.090
Why?
Biomarkers, Tumor
1
2014
461
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2013
406
0.080
Why?
Lung
1
2014
919
0.080
Why?
Cerebral Veins
1
2009
36
0.080
Why?
Follow-Up Studies
1
2014
2337
0.080
Why?
Brain Neoplasms
1
2012
305
0.080
Why?
Prospective Studies
1
2014
3067
0.070
Why?
Time Factors
1
2014
3617
0.070
Why?
Multiple Sclerosis
1
2009
207
0.070
Why?
Gene Products, tat
1
2005
14
0.060
Why?
Cysteine
1
2005
107
0.060
Why?
Arginine
1
2005
110
0.060
Why?
Peptide Fragments
1
2005
400
0.050
Why?
Female
6
2014
30705
0.050
Why?
HIV-1
1
2005
692
0.040
Why?
Magnetic Resonance Imaging
1
2009
2060
0.040
Why?
Middle Aged
2
2014
16317
0.040
Why?
Humans
7
2014
59360
0.040
Why?
Prognosis
2
2013
1600
0.040
Why?
HIV Infections
1
2005
913
0.040
Why?
Inhibins
1
2014
50
0.030
Why?
Follicle Stimulating Hormone
1
2014
82
0.030
Why?
Capecitabine
1
2012
10
0.030
Why?
Estradiol
1
2014
247
0.030
Why?
Radiography
1
2012
517
0.020
Why?
Antineoplastic Agents
1
2014
631
0.020
Why?
Biomarkers
1
2012
1306
0.020
Why?
Infant
1
2012
1486
0.020
Why?
Child, Preschool
1
2012
1782
0.020
Why?
Sensitivity and Specificity
1
2009
1093
0.020
Why?
tat Gene Products, Human Immunodeficiency Virus
1
2005
13
0.020
Why?
Receptors, CCR5
1
2005
56
0.020
Why?
Enzyme Activation
1
2005
359
0.010
Why?
Neovascularization, Pathologic
1
2005
137
0.010
Why?
Reproducibility of Results
1
2009
1561
0.010
Why?
Molecular Structure
1
2005
374
0.010
Why?
DNA Replication
1
2005
228
0.010
Why?
NF-kappa B
1
2005
460
0.010
Why?
Recombinant Proteins
1
2005
689
0.010
Why?
Child
1
2012
4174
0.010
Why?
Young Adult
1
2012
4267
0.010
Why?
Cell Line, Tumor
1
2005
1370
0.010
Why?
Cell Line
1
2005
1984
0.010
Why?
Adolescent
1
2012
5824
0.010
Why?
Male
2
2012
27739
0.010
Why?
Adult
1
2009
15669
0.010
Why?
Osa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_